Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 824 participants.
Also called NCT05907902
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 824 participants
- Sponsor
- Registry
-
NCT05907902
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05907902. Randomized; single masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
- Acronym
- AT-SUITABLE
- Condition
- Intracranial Aneurysm
- Condition
- Cerebrovascular Disease
- Intervention (Drug)
- Aspirin Enteric-coated Tablets
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct05907902- Content hash
1b9c4eca1959c3e6b9f3e5d933f1086a19f2277b736f1e2bf2a6c6fe850a82e4